Ebstein’s anomaly, meaning her tricuspid valve is malformed, and Wolf-Parkinson-White syndrome, which means her heart has an ...

With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.

We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

The global heart valve frame market is poised for significant growth over the coming years, driven by factors such as increasing prevalence of cardiovascular ...

LOS ANGELES -- Cardiac surgeons were urged to readjust their attitudes toward the tricuspid valve if they want to keep some ...

Two patients at MedStar Union Memorial Hospital receive recently FDA-approved Evoque Tricuspid Valve Replacements for severe tricuspid regurgitation. "These groundbreaking procedures represent a ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. The development of transcatheter valve repair therapies has opened a wide range of opportunities for ...

Edwards Lifesciences won FDA approval for its Evoque tricuspid valve replacement system. The company said it was the first transcatheter therapy to receive an FDA nod to treat tricuspid regurgitation.